World / Eyesight Disorders
Acucela And Otsuka Pharmaceutical Enter Co-Development Agreement For Rebamipide Ophthalmic Suspension For Dry Eye
05.09.2008 06:17
medicalnewstoday.com
Acucela Inc. and Otsuka Pharmaceutical Co., Ltd. announced that they have entered into a definitive agreement to co-develop Rebamipide ophthalmic suspension (hereinafter, Rebamipide), Otsuka's proprietary compound for the treatment of dry eye which is currently in Phase III clinical development in the United States.
World
Eyesight Disorders
Specific Brain Regions Show Increased Activity During Hallucinations
05.09.2008 06:17
medicalnewstoday.com
Ever seen or heard something that wasn't there? For most of us such experiences - termed hallucinations - are a normal, fleeting, brain glitch; yet for a few they are persistent, distressing and associated with a range of psychiatric, neurological and eye conditions. In the September Issue of Cortex Dominic H.
World
Eyesight Disorders
« Previous
0
Next »
English